I am a Neuroscientist and Postdoc at Washington University in St. Louis. My primary interest is in understanding how neurodevelopment mediates the effects of genetics and stress on the emergence of psychopathology, particularly substance use and depressive disorders. My research also includes work identifying replicable and reliable neural correlates of psychopathology, as well as work studying factors that influence the measurement of common neuroimaging metrics.
As a postdoc I have worked with Dr. Arpana Agrawal, Dr. Anna Manelis, and Dr. Erika Forbes. This work has focused on studying the reliability of neuroimaging measures of reward, identifying novel structural (cortical myelin) correlates of depression, and studying the association of depression with the neurodevelopment of reward function. My current work seeks to understand how genomic risk for substance use and depression influences neurodevelopment and the emergence of psychopathology in developing samples.
I completed my PhD in Neuroscience at Washington University in St Louis, where I worked with Dr. Ryan Bogdan and Dr. Deanna Barch. My dissertation was on the use of neural biomarkers to disentangle the causes and downstream consequences of alcohol use.
Outside of work you can find me playing with my cats, rock climbing, backpacking, and at indie/electronic shows.
Tobacco prevention has a proven public health strategy called also known as the “Vaccine”. It includes (1) Price increases (2) Smoke Free Policies (3)...
What is hemp? The congressional definition is anything less than 0.3% dry weight delta-9 THC. This presents a major loop hole, legalizing intoxicating products...
When Colorado voted to legalize marijuana, did they also mean to legalize high potency THC products that acts more like methamphetamine than marijuana? Listen...